Clinical Trial Update: A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas [Phase 2]

View source ↗

Summary

Phase 2 study of Zika vaccine mRNA-1893 in adults living in flavivirus-endemic and non-endemic areas has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zika Virus

Drugs mentioned

• mRNA-1893 (Zika vaccine mRNA-1893)

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Zika Virus | Phase 2 | Status: COMPLETED | Results posted: 2025-09-25